TRCT
EVO icon

Tower Research Capital (TRC)’s Evotec EVO Stock Holding History

Tower Research Capital (TRC)’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,597
Closed -$56.6K – 5268
2025
Q3 		$56.6K Buy
+15,597
New +$59.3K ﹤0.01% 2430
2025
Q2 		– Sell
-41,185
Closed -$138K – 5340
2025
Q1 		$138K Buy
+41,185
New +$168K ﹤0.01% 1594
2024
Q3 		– Sell
-109
Closed -$523 – 5782
2024
Q2 		$523 Buy
+109
New +$611 ﹤0.01% 5306
2023
Q2 		– Sell
-17
Closed – – 6124
2023
Q1 		$0 Hold
17
– – ﹤0.01% 5930
2022
Q4 		$0 Sell
17
-1,135
-99% -$9.93K ﹤0.01% 6015
2022
Q3 		$10K Buy
+1,152
New +$13.7K ﹤0.01% 4529
2022
Q1 		– Sell
-130
Closed -$3K – 6207
2021
Q4 		$3K Buy
+130
New +$3.03K ﹤0.01% 5437

Other funds holding EVO

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Tower Research Capital (TRC)'s EVO Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Evotec (EVO) in Q4 2025, closing a stake of 15,597 shares — an estimated $56.6K sold.

Tower Research Capital (TRC) first reported a position in EVO in Q4 2021 and held it in 7 quarters. The position peaked at $138K in Q1 2025. 44 funds tracked by Wall St. Rank hold EVO as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining Evotec position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 15,597 Evotec shares in Q4 2025, an estimated $56.6K.
  • Tower Research Capital (TRC) first reported a position in Evotec in Q4 2021 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s Evotec position peaked at $138K in Q1 2025.
  • 44 funds tracked by Wall St. Rank held Evotec as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.